Grace Therapeutics
GRCE
#9686
Rank
NZ$0.10 B
Marketcap
NZ$6.52
Share price
3.86%
Change (1 day)
-11.20%
Change (1 year)

Market capitalization of Grace Therapeutics (GRCE)

Market cap: NZ$0.10 Billion

As of January 2026 Grace Therapeutics has a market cap of NZ$0.10 Billion. This makes Grace Therapeutics the world's 9686th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Grace Therapeutics from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.10 B11.04%
2025NZ$90.84 M35.1%
2024NZ$67.24 M56.55%
2023NZ$42.95 M22.02%
2022NZ$35.2 M-56.91%
2021NZ$81.69 M16.21%
2020NZ$70.29 M-78.03%
2019NZ$0.31 B230.32%
2018NZ$96.86 M194.03%
2017NZ$32.94 M70.42%
2016NZ$19.33 M-51.34%
2015NZ$39.72 M-41.42%
2014NZ$67.8 M-47.91%
2013NZ$0.13 B-88.6%
2012NZ$1.14 B57.62%
2011NZ$0.72 B

End of Day market cap according to different sources

On Jan 6th, 2026 the market cap of Grace Therapeutics was reported to be:

NZ$86.8 Million
by Nasdaq info icon info icon
NZ$97.13 Million
by CompaniesMarketCap info icon info icon